| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.02 |